← Back to Dashboard

Boceprevir

NS3/4a protease inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(…
LHHCSNFAOIFYRV-DOVBMPENSA-N
DrugBankClinicalTrials.govPubMed

Clinical Development by Virus7

Hepacivirus C
HCV
Target: NS3/4A protease
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDA
Approval ref: AntiviralDbDB08873
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:32887884
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33645977
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33645977
Human coronavirus 229E
HCoV-229E
Target: Viral protease
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33645977
Human coronavirus NL63
HCoV-NL63
Target: Viral protease
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33645977
Betacoronavirus 1
HCoV-OC43
Target: Viral protease
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:33645977